Longitudinal assessment of anti-Mullerian hormone after cesarean section and influence of bilateral salpingectomy on ovarian reserve

被引:8
作者
Ida, Tsutomu [1 ]
Fujiwara, Hiroyuki [2 ]
Taniguchi, Yoshimi [1 ]
Kohyama, Akira [1 ]
机构
[1] Tokyo Metropolitan Tama Med Ctr, Dept Obstet & Gynecol, Fuchu, Tokyo, Japan
[2] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan
关键词
Anti-Mullerian hormone; Cesarean section; Ovarian function; Salpingectomy; Tubal ligation; Permanent contraception; SERUM ANTIMULLERIAN HORMONE; TUBAL-LIGATION; INHIBIN-B; WOMEN; STERILIZATION; AGE; HYSTERECTOMY; PREGNANCY; CANCER;
D O I
10.1016/j.contraception.2021.01.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study aimed to compare longitudinal changes in ovarian reserve markers after cesarean section (CS) with and without bilateral salpingectomy (BS). Study design: We prospectively enrolled women >35 weeks' gestation scheduled for CS alone or CS + BS and obtained blood samples for anti-Mullerian hormone prior to surgery and at 3 and 6 months after surgery. At the 3-month visit, we similarly performed transvaginal ultrasound for antral follicle count. Results: We enrolled 50 women; 30 underwent CS only and 20 underwent CS + BS. Although anti-Mullerian hormone level increased over 6 months of follow-up in both groups, no clinically important differences in the geometric mean (interquartile range) (ng/mL) were observed at any timepoint (baseline [0.69 {0.36-1.21} {CS only} vs 0.49 {0.32-2.10} {CS + BS}, p = 0.64]; 3 months [1.35 {0.58-3.13} vs 1.45 {1.04-2.25}, p = 0.79]; and 6 months [1.74 {0.93-4.45} vs 2.60 {1.41-5.10}, p =0.27]). Similarly, we detected no difference in antral follicle count. Conclusion: BS at the time of CS does not have a negative impact on ovarian reserve 6 months after surgery. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
  • [21] Anti-Mullerian hormone levels before and after uterine artery embolization
    McLucas, Bruce
    Voorhees, William D., III
    Snyder, Scott A.
    [J]. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2018, 27 (03) : 186 - 190
  • [22] Anti-Mullerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia
    Iwase, Akira
    Sugita, Atsuko
    Hirokawa, Wakana
    Goto, Maki
    Yamamoto, Eiko
    Takikawa, Sachiko
    Nakahara, Tatsuo
    Nakamura, Tomoko
    Kondo, Mika
    Kikkawa, Fumitaka
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 167 (02) : 194 - 198
  • [23] Anti-Mullerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review
    Gasparin, Andrese Aline
    da Silva Chakr, Rafael Mendonca
    Brenol, Claiton Viegas
    Palominos, Penelope Ester
    Xavier, Ricardo Machado
    Souza, Lucian
    Tavares Brenol, Joao Carlos
    Monticielo, Odirlei Andre
    [J]. REVISTA BRASILEIRA DE REUMATOLOGIA, 2015, 55 (04) : 363 - 367
  • [24] Comparison of the long-term effects of single-dose methotrexate and salpingectomy on ovarian reserve in terms of anti-mullerian hormone levels
    Ersoy, Gulcin Sahin
    Turhan, Omer Talip
    Sakin, Onder
    Bulut, Sadullah
    [J]. HUMAN FERTILITY, 2016, 19 (04) : 262 - 267
  • [25] Ovarian Reserve and Anti-Mullerian Hormone (AMH) in Mothers of Dizygotic Twins
    Van der Stroom, Elizabeth M. C.
    Konig, Tamar E.
    Vink, Jacqueline M.
    Boomsma, Dorret I.
    Lambalk, Cornelis B.
    [J]. TWIN RESEARCH AND HUMAN GENETICS, 2013, 16 (02) : 634 - 638
  • [26] Serum anti-Mullerian hormone concentration before and after salpingectomy for ectopic pregnancy
    Grynnerup, Anna Garcia-Alix
    Lindhard, Anette
    Sorensen, Steen
    Orskov, Mette
    Petersen, Kresten Rubeck
    Madsen, Lisbeth Buss
    Pilsgaard, Fie
    Lossl, Kristine
    Pinborg, Anja
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 37 (05) : 624 - 630
  • [27] Assessment of ovarian reserve with anti-Mullerian hormone in women following allogeneic hematopoietic cell transplantation
    Kaya, A. H.
    Tekgunduz, E.
    Akpinar, S.
    Bozdag, G.
    Yigenoglu, T. N.
    Merdin, A.
    Namdaroglu, S.
    Kayikci, O.
    Altuntas, F.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2019, 46 (01) : 127 - 130
  • [28] Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan
    Tremellen, Kelton
    Zander-Fox, Deidre
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2015, 55 (04) : 384 - 389
  • [29] Impact of tubal ligation on ovarian reserve as measured by anti-Mullerian hormone levels: a prospective cohort study
    Berwanger da Silva, Ana Luiza
    da Re, Camila
    Dietrich, Cristine
    Fuhrmeister, Isabela Piva
    Pimentel, Anita
    Corleta, Helena Von Eye
    [J]. CONTRACEPTION, 2013, 88 (06) : 700 - 705
  • [30] Anti-Mullerian hormone-predictive marker of ovarian reserve
    Rebhan, D.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2021, 19 (02): : 165 - 169